Neogen Corp
NEOG5.670USD
+0.210+3.85%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
1.23BMarket Cap
LossP/E TTM
More Details of Neogen Corp Company
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
Company Info
Ticker SymbolNEOG
Company nameNeogen Corp
IPO dateAug 23, 1989
CEOMr. Mikhael Nassif
Number of employees2974
Security typeOrdinary Share
Fiscal year-endAug 23
Address620 Lesher Pl
CityLANSING
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code48912
Phone15173729200
Websitehttps://www.neogen.com/
Ticker SymbolNEOG
IPO dateAug 23, 1989
CEOMr. Mikhael Nassif
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
90.47K
--
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
69.78K
-43.81%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
44.17K
-45.09%
Dr. William T. (Bill) Boehm, Ph.D.
Dr. William T. (Bill) Boehm, Ph.D.
Independent Director
Independent Director
36.21K
+1.75%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
21.92K
-21.70%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
13.24K
--
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
12.78K
--
Ms. Andrea F. Wainer
Ms. Andrea F. Wainer
Independent Director
Independent Director
6.09K
--
Mr. Thierry Bernard
Mr. Thierry Bernard
Independent Director
Independent Director
5.62K
--
Mr. Mikhael Nassif
Mr. Mikhael Nassif
President, Chief Executive Officer
President, Chief Executive Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
90.47K
--
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
69.78K
-43.81%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
44.17K
-45.09%
Dr. William T. (Bill) Boehm, Ph.D.
Dr. William T. (Bill) Boehm, Ph.D.
Independent Director
Independent Director
36.21K
+1.75%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
21.92K
-21.70%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
13.24K
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Culture Media & Other
77.74M
35.18%
Bacterial & General Sanitation
39.88M
18.05%
Rodenticides, Insecticides & Disinfectants
35.64M
16.13%
Genomics Services
22.70M
10.27%
Natural Toxins, Allergens & Drug Residues
17.59M
7.96%
Other
27.41M
12.41%
By RegionUSD
Name
Revenue
Proportion
Domestic
115.36M
52.21%
International
105.61M
47.79%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Culture Media & Other
77.74M
35.18%
Bacterial & General Sanitation
39.88M
18.05%
Rodenticides, Insecticides & Disinfectants
35.64M
16.13%
Genomics Services
22.70M
10.27%
Natural Toxins, Allergens & Drug Residues
17.59M
7.96%
Other
27.41M
12.41%
Shareholding Stats
Updated: Tue, Aug 19
Updated: Tue, Aug 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.68%
The Vanguard Group, Inc.
10.83%
Clarkston Capital Partners, LLC
6.45%
Gates Capital Management, Inc.
5.89%
Southpoint Capital Advisors LP
4.60%
Other
59.55%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.68%
The Vanguard Group, Inc.
10.83%
Clarkston Capital Partners, LLC
6.45%
Gates Capital Management, Inc.
5.89%
Southpoint Capital Advisors LP
4.60%
Other
59.55%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.43%
Investment Advisor/Hedge Fund
36.90%
Hedge Fund
15.85%
Research Firm
4.89%
Sovereign Wealth Fund
4.26%
Pension Fund
1.51%
Individual Investor
0.66%
Bank and Trust
0.55%
Private Equity
0.29%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
720
240.23M
110.60%
-42.75M
2025Q1
753
280.62M
129.30%
-9.42M
2024Q4
764
265.86M
122.55%
-15.84M
2024Q3
778
258.29M
119.19%
-21.39M
2024Q2
791
255.45M
117.89%
-8.15M
2024Q1
783
241.86M
111.66%
-5.94M
2023Q4
783
234.38M
108.27%
-1.28M
2023Q3
770
225.33M
104.20%
-18.20M
2023Q2
761
232.20M
107.41%
-2.78M
2023Q1
759
225.00M
104.19%
-1.65M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
28.62M
13.19%
+5.44M
+23.46%
Mar 31, 2025
The Vanguard Group, Inc.
23.51M
10.83%
+1.91M
+8.86%
Mar 31, 2025
Clarkston Capital Partners, LLC
6.28M
2.89%
+3.41M
+118.93%
Mar 31, 2025
Gates Capital Management, Inc.
9.16M
4.22%
+9.16M
--
Mar 31, 2025
William Blair Investment Management, LLC
13.56M
6.25%
-787.83K
-5.49%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.44M
3.89%
+1.50M
+21.56%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
14.81M
6.82%
-2.67M
-15.27%
Mar 31, 2025
State Street Global Advisors (US)
8.61M
3.97%
+282.73K
+3.40%
Mar 31, 2025
Mackenzie Investments
7.76M
3.57%
-67.86K
-0.87%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
Federated Hermes MDT Small Cap Core ETF
0.48%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Inspire Small/Mid Cap ESG ETF
0.24%
Invesco S&P SmallCap 600 Pure Value ETF
0.2%
Amplify Etho Climate Leadership U.S. ETF
0.17%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.07%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.06%
Proshares Ultra Russell 2000
0.04%
View more
Federated Hermes MDT Small Cap Core ETF
Proportion0.48%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.43%
Inspire Small/Mid Cap ESG ETF
Proportion0.24%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.2%
Amplify Etho Climate Leadership U.S. ETF
Proportion0.17%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proportion0.1%
iShares ESG Select Screened S&P Small-Cap ETF
Proportion0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proportion0.07%
JPMorgan BetaBuilders US Small Cap Equity ETF
Proportion0.06%
Proshares Ultra Russell 2000
Proportion0.04%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
May 12, 2021
Split
1→2
Date
Type
Ratio
May 12, 2021
Split
1→2
